Limits...
IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation.

Dong Z, Lu X, Yang Y, Zhang T, Li Y, Chai Y, Lei W, Li C, Ai L, Tai W - BMC Pulm Med (2015)

Bottom Line: IL-27 inhibited the development of CD4(+) IL-17(+), CD4(+) IL-4(+) T, and CD4(+) Foxp3(+) cells and the secretion of IL-17, IL-4, IL-6, and TGF-ß.IL-27 induced the production of CD4(+) IL-10(+) and CD4(+) INF-γ(+) T cells.IL-27 decreased the levels of phosphorylated STAT1, STAT3, STAT5, Smad1, and Smad3 but increased the level of SOCS3.

View Article: PubMed Central - PubMed

Affiliation: Department of Respiratory, The 2nd Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. dongkm@hotmail.com.

ABSTRACT

Background: Interleukin-27 (IL-27) is a multifunctional cytokine with both pro-inflammatory and immunoregulatory functions. At present, the role of IL-27 in pulmonary fibrosis remains unknown.

Methods: In this study, we observed the expression of IL-27/IL-27R in a mouse model of bleomycin (BLM)-induced pulmonary fibrosis. We verified the role of IL-27 using hematoxylin and eosin as well as Masson's staining methods and measuring the content of hydroxyproline as well as collagen I and III. We assessed the differentiation of T lymphocytes in the spleen and measured the concentration of cytokines in bronchoalveolar lavage fluid (BALF) and the expression level of relevant proteins in the JAK/STAT and TGF-ß/Smad signaling pathways in lung tissue.

Results: Increased IL-27 expression in BLM-induced pulmonary fibrosis was noted. IL-27 treatment may alleviate pulmonary fibrosis and increase the survival of mice. IL-27 inhibited the development of CD4(+) IL-17(+), CD4(+) IL-4(+) T, and CD4(+) Foxp3(+) cells and the secretion of IL-17, IL-4, IL-6, and TGF-ß. IL-27 induced the production of CD4(+) IL-10(+) and CD4(+) INF-γ(+) T cells. IL-27 decreased the levels of phosphorylated STAT1, STAT3, STAT5, Smad1, and Smad3 but increased the level of SOCS3.

Conclusions: This study demonstrates that IL-27 potentially attenuates BLM-induced pulmonary fibrosis by regulating Th17 differentiation and cytokine secretion.

No MeSH data available.


Related in: MedlinePlus

The concentration of cytokines in the BALF of the different groups on days 7 and 28. The concentration (in pg/ml) of (A) IL-4; (B) IL-6; (C) IL-10 ; (D) TGF-β; (E) IFN-γ; and (F) IL-17. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4340860&req=5

Fig4: The concentration of cytokines in the BALF of the different groups on days 7 and 28. The concentration (in pg/ml) of (A) IL-4; (B) IL-6; (C) IL-10 ; (D) TGF-β; (E) IFN-γ; and (F) IL-17. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.

Mentions: We also measured the concentrations of IL-4, IL-6, IL-10, IL-17, IFN-γ and TGF-β in the BALF of mice at days 7 and 28 using an ELISA. In the BIPF model, IL-4, IL-10, IL-17 and TGF-β were significantly increased compared with the control group at days 7 and 28. IL-6 was also increased at day 28. Conversely, IFN-γ was significantly decreased at days 7 and 28. These trends were exacerbated following IL-27 antibody treatment. Conversely, IL-27 treatment reversed these trends (Figure 4A-F). Therefore, we speculate that IL-27 may inhibit pulmonary fibrosis by influencing the expression of inflammatory factors.Figure 4


IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation.

Dong Z, Lu X, Yang Y, Zhang T, Li Y, Chai Y, Lei W, Li C, Ai L, Tai W - BMC Pulm Med (2015)

The concentration of cytokines in the BALF of the different groups on days 7 and 28. The concentration (in pg/ml) of (A) IL-4; (B) IL-6; (C) IL-10 ; (D) TGF-β; (E) IFN-γ; and (F) IL-17. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4340860&req=5

Fig4: The concentration of cytokines in the BALF of the different groups on days 7 and 28. The concentration (in pg/ml) of (A) IL-4; (B) IL-6; (C) IL-10 ; (D) TGF-β; (E) IFN-γ; and (F) IL-17. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01.
Mentions: We also measured the concentrations of IL-4, IL-6, IL-10, IL-17, IFN-γ and TGF-β in the BALF of mice at days 7 and 28 using an ELISA. In the BIPF model, IL-4, IL-10, IL-17 and TGF-β were significantly increased compared with the control group at days 7 and 28. IL-6 was also increased at day 28. Conversely, IFN-γ was significantly decreased at days 7 and 28. These trends were exacerbated following IL-27 antibody treatment. Conversely, IL-27 treatment reversed these trends (Figure 4A-F). Therefore, we speculate that IL-27 may inhibit pulmonary fibrosis by influencing the expression of inflammatory factors.Figure 4

Bottom Line: IL-27 inhibited the development of CD4(+) IL-17(+), CD4(+) IL-4(+) T, and CD4(+) Foxp3(+) cells and the secretion of IL-17, IL-4, IL-6, and TGF-ß.IL-27 induced the production of CD4(+) IL-10(+) and CD4(+) INF-γ(+) T cells.IL-27 decreased the levels of phosphorylated STAT1, STAT3, STAT5, Smad1, and Smad3 but increased the level of SOCS3.

View Article: PubMed Central - PubMed

Affiliation: Department of Respiratory, The 2nd Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. dongkm@hotmail.com.

ABSTRACT

Background: Interleukin-27 (IL-27) is a multifunctional cytokine with both pro-inflammatory and immunoregulatory functions. At present, the role of IL-27 in pulmonary fibrosis remains unknown.

Methods: In this study, we observed the expression of IL-27/IL-27R in a mouse model of bleomycin (BLM)-induced pulmonary fibrosis. We verified the role of IL-27 using hematoxylin and eosin as well as Masson's staining methods and measuring the content of hydroxyproline as well as collagen I and III. We assessed the differentiation of T lymphocytes in the spleen and measured the concentration of cytokines in bronchoalveolar lavage fluid (BALF) and the expression level of relevant proteins in the JAK/STAT and TGF-ß/Smad signaling pathways in lung tissue.

Results: Increased IL-27 expression in BLM-induced pulmonary fibrosis was noted. IL-27 treatment may alleviate pulmonary fibrosis and increase the survival of mice. IL-27 inhibited the development of CD4(+) IL-17(+), CD4(+) IL-4(+) T, and CD4(+) Foxp3(+) cells and the secretion of IL-17, IL-4, IL-6, and TGF-ß. IL-27 induced the production of CD4(+) IL-10(+) and CD4(+) INF-γ(+) T cells. IL-27 decreased the levels of phosphorylated STAT1, STAT3, STAT5, Smad1, and Smad3 but increased the level of SOCS3.

Conclusions: This study demonstrates that IL-27 potentially attenuates BLM-induced pulmonary fibrosis by regulating Th17 differentiation and cytokine secretion.

No MeSH data available.


Related in: MedlinePlus